Edwardsiella tarda antidiotypic antibody genetic engineering vaccine and preparation method thereof
A genetically engineered vaccine, idiotype antibody technology, applied in genetic engineering, botanical equipment and methods, biochemical equipment and methods, etc., can solve problems that have not been reported in the literature
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] In the previous research of the present invention, the Edwardsiella tarda anti-idiotypic monoclonal antibody hybridoma cell line 1E11 has been successfully prepared, which can secrete an anti-idiotypic antibody with antigen "internal image" and high protection rate. In order to construct the Edwardsiella tarda anti-idiotypic antibody genetic engineering vaccine, its implementation method is:
[0028] 1. Delayed recovery of Edwardsiella anti-idiotypic monoclonal hybridoma cells:
[0029] Take out the monoclonal hybridoma cell line 1E11 that secretes Edwardsiella tarda anti-idiotype from the frozen liquid nitrogen tank, put it in a 37°C water bath to thaw quickly, add 10 mL of RPMI-1640 serum-free culture medium preheated at 37°C, Centrifuge at 1000rpm for 10min, discard the supernatant; add 5mL of 20% RPMI-1640 culture solution containing calf serum, centrifuge at 1000rpm for 10min, discard the supernatant; add 10mL of RPMI-1640 culture solution Gently pipette the pelle...
Embodiment 2
[0108] Materials and methods
[0109] 1 Strains, plasmids and main reagents Plasmid PET28a and strain E.coli BL21(DE3) are products of Novagen, USA. RPMI1640 is a product of GibcoBRL Company, RNA extraction reagents are purchased from Takara Company, and RT-PCR kits are products of Invitrogen Company of the United States. Plasmid extraction kits and gel recovery kits are purchased from Beijing Biotech Company. PCR reagents and ligation reagents were purchased from Beijing Tianwei Times Company.
[0110]Lysis solution: 50mmol Tris-HCl, 0.5mmol EDTA, 5mmol DTT, 5% glycerol, pH8.0.
[0111] Refolding solution: 25mmol Tris-HCl, 10mmol NaCl, 0.1mol urea, 1% glycerol, pH 8.0.
[0112] Gradient dialysate: 1.25mmol Tris-HCl, 10mmol NaCl, 0.05mol urea, 1% glycerin, pH8.0.
[0113] 2.25mmol Tris-HCl, 10mmol NaCl, 0.01mol urea, 1% glycerin, pH8.0.
[0114] 2. Preparation method of Edwardsiella tarda anti-idiotypic antibody genetic engineering vaccine
[0115] Other situa...
Embodiment 3
[0121] Immunoprotective effect of Edwardsiella tarda anti-idiotypic antibody genetically engineered vaccine
[0122] 1. Fish used in the test: American redfish, also known as red meager, belongs to Perciformes and Totoaba family. Sciaenops ocellatus (Linnaeus)), a total of 200 tails were used in the experiment, divided into two groups, the injection group and the control group, 100 tails in each group.
[0123] 2. Method
[0124] The Edwardsiella tarda anti-idiotypic antibody and Freund's incomplete adjuvant were mixed 1:1, and the American redfish was immunized by intraperitoneal injection. Each fish was injected with 0.1mL (containing 10-20μg of antibody). One month after the immunization, 5 times the half-lethal dose The American redfish was challenged by intraperitoneal injection of Edwardsiella tarda, and the protective effect of anti-idiotypic antibody genetic engineering vaccine on American redfish was observed.
[0125] Ten fish were randomly selected from each group...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com